Skip to main content
Richard Myers, MD, Psychiatry, Grand Rapids, MI

RichardMyersMD

Psychiatry Grand Rapids, MI

Psychiatrist at Plexus Psychiatric Medicine

Dr. Myers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Myers' full profile

Already have an account?

  • Office

    4833 E Meadows Ct SE
    Grand Rapids, MI 49546
    Phone+1 616-288-3939
    Fax+1 888-706-7646

Education & Training

  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1983

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1997 - 2025
  • CA State Medical License
    CA State Medical License 2014 - 2023
  • MD State Medical License
    MD State Medical License 2021 - 2023
  • NH State Medical License
    NH State Medical License 2021 - 2023
  • GA State Medical License
    GA State Medical License 2021 - 2022
  • OR State Medical License
    OR State Medical License 2021 - 2022
  • AL State Medical License
    AL State Medical License 2021 - 2021
  • American Board of Psychiatry and Neurology Psychiatry
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Kansas Board of Regents Takes Step Toward Evaluation of Campus Health Clinics
    Kansas Board of Regents Takes Step Toward Evaluation of Campus Health ClinicsSeptember 16th, 2021
  • HudsonAlpha’s Neil Lamb: A Unique Combination of Researcher and Educator
    HudsonAlpha’s Neil Lamb: A Unique Combination of Researcher and EducatorAugust 18th, 2021
  • IMIDomicsTM Closes $16.5 Million Series A Financing to Advance Its Precision Discovery Platform for Immune-Mediated Inflammatory Diseases
    IMIDomicsTM Closes $16.5 Million Series A Financing to Advance Its Precision Discovery Platform for Immune-Mediated Inflammatory DiseasesJuly 27th, 2021